There are therapies available that address the underlying cause of hATTR amyloidosis. These treatments can help by decreasing the amount of TTR protein that’s made in the body.
Liver transplant is also an option for some patients who meet certain eligibility criteria.
Due to the progressive nature of hereditary ATTR (hATTR) amyloidosis, managing symptoms is an ongoing process. Physicians may prescribe medications to treat some of these symptoms and reduce the daily impact they may have.
Additional treatment options for hATTR amyloidosis are currently being researched.